Cargando…
FXYD proteins and sodium pump regulatory mechanisms
The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953255/ https://www.ncbi.nlm.nih.gov/pubmed/33688925 http://dx.doi.org/10.1085/jgp.202012633 |
_version_ | 1783663880520597504 |
---|---|
author | Yap, John Q. Seflova, Jaroslava Sweazey, Ryan Artigas, Pablo Robia, Seth L. |
author_facet | Yap, John Q. Seflova, Jaroslava Sweazey, Ryan Artigas, Pablo Robia, Seth L. |
author_sort | Yap, John Q. |
collection | PubMed |
description | The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family of regulators has in common a domain containing a Phe-X-Tyr-Asp (FXYD) motif, two conserved glycines, and one serine residue. In humans, there are seven tissue-specific FXYD proteins that differentially modulate NKA kinetics as appropriate for each system, providing dynamic responsiveness to changing physiological conditions. Our understanding of how FXYD proteins contribute to homeostasis has benefitted from recent advances described in this review: biochemical and biophysical studies have provided insight into regulatory mechanisms, genetic models have uncovered remarkable complexity of FXYD function in integrated physiological systems, new posttranslational modifications have been identified, high-resolution structural studies have revealed new details of the regulatory interaction with NKA, and new clinical correlations have been uncovered. In this review, we address the structural determinants of diverse FXYD functions and the special roles of FXYDs in various physiological systems. We also discuss the possible roles of FXYDs in protein trafficking and regulation of non-NKA targets. |
format | Online Article Text |
id | pubmed-7953255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79532552021-10-05 FXYD proteins and sodium pump regulatory mechanisms Yap, John Q. Seflova, Jaroslava Sweazey, Ryan Artigas, Pablo Robia, Seth L. J Gen Physiol Review The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family of regulators has in common a domain containing a Phe-X-Tyr-Asp (FXYD) motif, two conserved glycines, and one serine residue. In humans, there are seven tissue-specific FXYD proteins that differentially modulate NKA kinetics as appropriate for each system, providing dynamic responsiveness to changing physiological conditions. Our understanding of how FXYD proteins contribute to homeostasis has benefitted from recent advances described in this review: biochemical and biophysical studies have provided insight into regulatory mechanisms, genetic models have uncovered remarkable complexity of FXYD function in integrated physiological systems, new posttranslational modifications have been identified, high-resolution structural studies have revealed new details of the regulatory interaction with NKA, and new clinical correlations have been uncovered. In this review, we address the structural determinants of diverse FXYD functions and the special roles of FXYDs in various physiological systems. We also discuss the possible roles of FXYDs in protein trafficking and regulation of non-NKA targets. Rockefeller University Press 2021-03-10 /pmc/articles/PMC7953255/ /pubmed/33688925 http://dx.doi.org/10.1085/jgp.202012633 Text en © 2021 Yap et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Review Yap, John Q. Seflova, Jaroslava Sweazey, Ryan Artigas, Pablo Robia, Seth L. FXYD proteins and sodium pump regulatory mechanisms |
title | FXYD proteins and sodium pump regulatory mechanisms |
title_full | FXYD proteins and sodium pump regulatory mechanisms |
title_fullStr | FXYD proteins and sodium pump regulatory mechanisms |
title_full_unstemmed | FXYD proteins and sodium pump regulatory mechanisms |
title_short | FXYD proteins and sodium pump regulatory mechanisms |
title_sort | fxyd proteins and sodium pump regulatory mechanisms |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953255/ https://www.ncbi.nlm.nih.gov/pubmed/33688925 http://dx.doi.org/10.1085/jgp.202012633 |
work_keys_str_mv | AT yapjohnq fxydproteinsandsodiumpumpregulatorymechanisms AT seflovajaroslava fxydproteinsandsodiumpumpregulatorymechanisms AT sweazeyryan fxydproteinsandsodiumpumpregulatorymechanisms AT artigaspablo fxydproteinsandsodiumpumpregulatorymechanisms AT robiasethl fxydproteinsandsodiumpumpregulatorymechanisms |